Health Advocate program for young liver transplant recipients
HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients
NA · University of California, San Francisco · NCT06386198
This study is testing a new program that adds a Health Advocate to help young adults who had a liver transplant manage their care and connect with resources as they transition to adult healthcare.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 25 Years |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Locations | 2 sites (San Francisco, California and 1 other locations) |
| Trial ID | NCT06386198 on ClinicalTrials.gov |
What this trial studies
The HEAL-Tx Transition of Care Pilot is an intervention designed to integrate a Health Advocate into the transplant team to assist adolescents transitioning to adult liver transplant care. This pilot program aims to assess the feasibility and acceptability of the Health Advocate's role, which includes coordinating medical care, providing financial assistance, and connecting patients with community resources. By focusing on adolescents aged 18-25 who have received a liver transplant over a year ago, the study seeks to improve self-management and communication between patients and healthcare providers. The effectiveness of this intervention will be measured using the RE-AIM framework.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 18-25 who have received a liver transplant more than one year ago and face unmet social risks.
Not a fit: Patients with significant cognitive impairment or those who do not meet the age criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance the transition process for young liver transplant recipients, leading to better health outcomes and improved quality of life.
How similar studies have performed: Other studies have shown success with similar health advocate approaches in improving patient outcomes, indicating potential for this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient has received a liver transplant \>1 year ago 2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program. 3. Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0. 4. Patient will be transferred to adult transplant team in \<6 months. 5. Patient can read and write English or Spanish 6. Patient is between 18-25 years old and can provide informed consent. 7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom. Exclusion Criteria: * Patient has significant cognitive impairment. * Does not meet age criteria * Patient is a ward of the state. * Non-English, non-Spanish speakers. * Non-US residents.
Where this trial is running
San Francisco, California and 1 other locations
- University of California San Francisco — San Francisco, California, United States (RECRUITING)
- Children's Healthcare of Atlanta — Atlanta, Georgia, United States (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Sharad Wadhwani, MD, MPH — University of California, San Francisco
- Study coordinator: Sharad Wadhwani, MD, MPH
- Email: sharad.wadhwani@ucsf.edu
- Phone: 510-428-3058
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Liver Transplant, Complications, Pediatric ALL, Health Advocate, Patient Navigator